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KinaseThe Hippo (Hpo) signaling pathway controls cell growth, proliferation and apoptosis in both Drosophila and
vertebrates. In Drosophila, Hpo signaling regulates gene expression by inhibiting a transcription complex
consisting of the transcriptional coactivator Yorkie (Yki) and the TEAD/TEF family of transcription factor
Scalloped (Sd). Here we provide genetic evidence that both isoforms of 14-3-3, 14-3-3ɛ and 14-3-3ζ,
regulate Yki activity through modulating its subcellular localization. Inactivation of 14-3-3 by RNAi or genetic
mutations enhanced whereas overexpression of 14-3-3 suppressed tissue overgrowth induced by Yki
overexpression. Loss of 14-3-3 resulted in the accumulation of Yki in the nucleus. We found that regulation
of Yki by 14-3-3 was mediated by phosphorylation of Yki at S168. In addition, we found that Hpo signaling
also inhibited Yki nuclear localization and activity by phosphorylating Yki at S111 and S250, and this
inhibition appears to be independent of 14-3-3. Finally, we provided evidence that Hpo signaling restricted
Yki nuclear localization depending on CRM1-mediated nuclear export.
© 2009 Elsevier Inc. All rights reserved.Introduction
How the size of an organ is controlled has remained an unsolved
mystery in development biology. The organ size is mainly determined
by the number and size of its constituent cells, and both extrinsic
environmental factors such as hormones and nutrients and intrinsic
growth-control mechanisms contribute to the control of tissue growth
by coordinately regulating cell growth, cell proliferation and cell
apoptosis (Bryant and Simpson, 1984; Conlon and Raff, 1999). Genetic
screens in Drosophila have identiﬁed a large number of tumor
suppressor genes,mutations ofwhich result in overgrowth of imaginal
disc derivatives (Hariharan and Bilder, 2006). Several tumor suppres-
sor genes, including warts (wts) (Justice et al., 1995; Xu et al., 1995),
salvador (sav) (Tapon et al., 2002) and hpo (also called dMST) (Harvey
et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003;Wu
et al., 2003), fat (Bennett and Harvey, 2006; Cho et al., 2006; Mahoney
et al., 1991; Silva et al., 2006; Willecke et al., 2006) and expanded (ex)
(Cho et al., 2006; Hamaratoglu et al., 2006; Maitra et al., 2006; Pellock
et al., 2007) deﬁne a common tumor suppressor pathway, the so-
called Hpo pathway (Pan, 2007; Zhang et al., 2009).
The Hpo pathway regulates tissue growth and organ size by inhi-
biting cell growth and proliferation as well as by promoting apoptosisg).
ll rights reserved.through modulating the expression of genes including cyclin E, diap1
and bantam that are involved in these cellular processes (Harvey et al.,
2003; Jia et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002;
ThompsonandCohen, 2006;Udanet al., 2003;Wuet al., 2003). The core
components of the Hpo pathway, Hpo, Sav, Wts and Mats, constitute a
kinase cascade. The upstream kinase Hpo, the Drosophila homolog of
mammalian Ste20 family kinases MST1 and MST2, associates with the
WW-domain containing scaffolding protein Sav to phosphorylate and
activate the downstream kinaseWts, which belongs to the nuclear Dbf-
2-related (NDR) kinase family (Harvey et al., 2003; Jia et al., 2003;
Justice et al., 1995; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al.,
2003; Wu et al., 2003; Xu et al., 1995). The phosphorylated Wts
interactswith a cofactorMats, which is also phosphorylated byHpo (Lai
et al., 2005;Wei et al., 2007), to regulate the expression of Hpo pathway
target genes by phosphorylating a transcriptional coactivator Yki, the
Drosophila homolog of Yap (Huang et al., 2005).
Recently, the TEAD/TEF family transcription factor Scalloped (Sd)
has been implicated as a transcription factor for the Hpo pathway. Sd
both genetically and physically interacts with Yki and is essential for
tissue overgrowth induced by Yki overexpression or by loss of Hpo or
Wts (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008). Sd binds
to the enhancer elements of diap1 (Wu et al., 2008; Zhang et al., 2008).
In addition, Sd promotes nuclear localization of Yki and recruits Yki to
the diap1 promoter (Zhang et al., 2008). On the other hand,
phosphorylation of Yki at Ser168 by Hpo signaling restricts Yki nuclear
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Mutating Ser168 toAla promotes Yki nuclear localization and its ability
to induce tissue overgrowthwhen overexpressed in vivo and rendered
Yki more resistant to Hpo-mediated repression (Dong et al., 2007; Oh
and Irvine, 2008; Zhang et al., 2008). Similarly, mutating the
corresponding Ser residue in Yap (Ser127) promoted Yap nuclear
localization and activity and rendered Yap more resistant to Lats-
mediated inhibition (Hao et al., 2008; Zhao et al., 2007). In response to
Hpo signaling, Yki/Yap interacted with 14-3-3 whereas YkiS168A/
YapS127A failed to bind 14-3-3 (Dong et al., 2007; Oh and Irvine, 2008;
Zhao et al., 2007). As 14-3-3 binding often regulate protein subcellular
localization including nuclear/cytoplasmic shuttling (Fu et al., 2000),
these observations imply that phosphorylation of Yki/Yap at S168/
S127 restrict their nuclear localization by promoting 14-3-3 binding.
However, genetic evidence for the involvement of 14-3-3 in the Hpo
pathway and in regulating Yki /Yap nuclear localization is still lacking.
14-3-3 proteins are highly conserved and ubiquitously expressed
phosphor-S/T binding proteins. 14-3-3 proteins form homo- and
hetero-dimers and participate in many cellular processes including
signal transduction through binding to speciﬁc phosphorylated sites
on their target partners (Mackintosh, 2004;Morrison, 2009). There are
two isoforms of 14-3-3 in Drosophila, 14-3-3ɛ and 14-3-3ζ/ Leonardo
that often act redundantly in many cellular processes (Acevedo et al.,
2007; Benton and St Johnston, 2003). Here we provide evidence that
both 14-3-3 isoforms are involved in modulating Yki activity through
regulating its subcellular localization.We showed that inactivating 14-
3-3 either by RNAi knockdown or genetic mutations enhanced tissue
overgrowth induced by Yki overexpression whereas excess amounts
of 14-3-3 suppressed Yki-induced overgrowth phenotype. In addition,
14-3-3 RNAi resulted in the accumulation of Yki in the nucleus. We
provided both genetic and biochemical evidence that regulation of Yki
by 14-3-3 is through phosphorylation of Yki at Ser168. Furthermore,
we provided evidence that Hpo signaling inhibited Yki nuclear
localization and activity through two additional phosphorylation
sites, Ser111 and Ser250, and this regulation appeared to be 14-3-3
independent. Finally, we provided evidence that Yki subcellular
localization is regulated by CRM1-mediated nuclear export.
Materials and methods
Mutants and transgenes
The 14-3-3ζ-RNAi transgene was obtained from VDRC (http://
www.vdrc.at/). 14-3-3εj2B10 and 14-3-3ζ12BL are strong loss-of-
function alleles (http://ﬂybase.org/). To construct UAS-14-3-3ε-RNAi
transgenes, genomic DNA fragment corresponding to 14-3-3ε aa45-
108 was ampliﬁed by PCR and subcloned between the BglII and KpnI
sites of the pUAST vector. The corresponding cDNA fragment was
inserted in a reverse orientation between KpnI and XbaI sites. Yki point
mutations were generated by PCR-based site directed mutagenesis
and veriﬁed by DNA sequence. The Yki coding sequencewas ampliﬁed
by PCR and subcloned in frame into the pUAST-6Myc vector (Zhang et
al., 2008). To construct wild-type and mutant forms of attB-UAS-Myc-
Yki transgenes , a pUAST vector with attB sequence inserted upstream
of the UAS-binding sites was used (Liu et al., 2007). The vas-phi-zh2A-
VK5 ﬂies were used to generate Yki transformants inserted at the 75B1
attP locus. To construct HA-14-3-3, 14-3-3 coding sequences were
ampliﬁed by PCR and subcloned in frame into the pUAST-3HA vector
(Zhang et al., 2008).
Cell culture, transfection, immunoprecipitation, western blot analysis
and luciferase reporter assay
S2 cells were cultured in Drosophila Schneider's Medium (Invitro-
gen) with 10% fetal bovine serum, 100U/ml of penicillin, and 100ug/
ml of Streptomycin. Transfection was carried out using CalciumPhosphate Transfection Kit (Specialty Media) according to manu-
facturer's instructions. A ubiquitin-Gal4 construct was cotransfected
with pUAST expression vectors for all the transfection experiments.
Immunoprecipitation andwestern blot analysis were performed using
standard protocols as previously described (Zhang et al., 2008).
Antibodies used were mouse anti-HA (Santa Cruz), mouse anti-Myc
(Santa Cruz). For Luciferase reporter assays, S2 cells were transfected
with 3×Sd2-Luc and copia-renilla luciferase reporter constructs
(Zhang et al., 2008) in 12-well plates together with constructs ex-
pressing Sd and differentmutant forms of Yki. Cells were incubated for
48 h after transfection and the luciferase reporter assaywas performed
using the Dual-Luciferase reporter assay system (Promega). Dual-
Luciferase measurements were performed in triplicate using FLUOstar
OPTIMA (BMG LABETCH).
Immunostaining
Immunostaining of imaginal discs and cultured cells was carried
out as described (Jia et al., 2004; Jiang and Struhl, 1995). Antibodies or
dyes used in this study were as follows: mouse anti-Myc (Santa Cruz),
rabbit anti-HA (Santa Cruz), rabbit anti-Yki (Oh and Irvine, 2008) and
7-AAD (Molecular Probes). For LMB treatment of S2 cells, LMB was
added at a concentration of 20 nM for 4 h before cells were collected.
Results
Knockdown of 14-3-3 enhances Yki-induced overgrowth
To investigate whether 14-3-3 proteins regulate Yki activity, we
used transgenic RNAi technique (Kalidas and Smith, 2002; Kennerdell
and Carthew, 2000) to knockdown either 14-3-3ɛ or 14-3-3ζ and
examined whether reduction in 14-3-3 activity would modify Yki-
induced overgrowth phenotype. Overexpression of UAS-Yki posterior
to the morphogenetic furrow (MF) using the GMR-Gal4 driver
(referred to as GMR-Yki) resulted in enlarged eyes (Figs. 1B, B′) (Wu
et al., 2008; Zhang et al., 2008). Coexpression of either UAS-14-3-3ɛ-
RNAi or UAS-14-3-3ζ-RNAi transgene enhanced the eye overgrowth
phenotype (Figs. 1C–D′), whereas expression of neither RNAi
transgene with GMR-Gal4 in otherwise wild-type eyes caused any
visible phenotypes (data not shown). The effect of 14-3-3 RNAi on
GMR-Yki is speciﬁc as 14-3-3 RNAi did not modify the overgrowth
phenotype caused by expressing an active form of insulin receptor
(data not shown).
To determine whether modiﬁcation of the GMR-Yki phenotype
was due to inactivation of 14-3-3 rather than off-target effects, we
generated transgenes that express either 14-3-3ɛ or 14-3-3ζ under
the control of the UAS promoter. As shown in Fig. 1, enhancement of
the GMR-Yki phenotype by 14-3-3ɛ RNAi was signiﬁcantly suppressed
by coexpression of UAS-14-3-3ζ (Figs. 1E and E′) but not by
coexpression of UAS-14-3-3ɛ (Figs. 1F and F′). Similarly, coexpression
of UAS-14-3-3ɛ but not UAS-14-3-3ζ suppressed the enhancement of
GMR-Yki phenotype caused by 14-3-3ζ RNAi (Figs. 1G–H′). The
isoform-speciﬁc rescue suggests that the transgenic RNAi for each
isoform did not signiﬁcantly interfere with the other isoform and that
increasing the level of one 14-3-3 isoform could compensate for the
loss of the other.
As an independent approach to determine whether loss of 14-3-3
would modulate Yki activity, we turned to loss-of-function mutations
of 14-3-3. 14-3-3ɛj2B10 and 14-3-3ζ12BL are strong loss-of-function
alleles of 14-3-3ɛ and 14-3-3ζ, respectively (ﬂybase). We found that
either 14-3-3ɛj2B10 or 14-3-3ζ12BL heterozygosity could enhance the
GMR-Yki phenotype (Figs. 1J–K′). 14-3-3ɛj2B10 and 14-3-3ζ12BL double
heterozygosity enhanced the GMR-Yki phenotype more profoundly
(Figs. 1L and L′). Taken together with the results from the RNAi
experiments, these observations suggest that both 14-3-3 isoforms
are involved in restricting Yki activity.
Fig. 1. Loss of function of either 14-3-3 isoform can enhance Yki-induced eye overgrowth. (A–L′) Side views (A–L) or dorsal views (A′–L′) of adult eyes of GMR-Gal4 (A and A′), GMR-
Gal4 UAS-Yki (B and B′), GMR-Gal4 UAS-Yki; UAS-14-3-3εRNAi (C and C′), GMR-Gal4 UAS-Yki; UAS-14-3-3ζRNAi (D and D′), GMR-Gal4 UAS-Yki; UAS-14-3-3εRNAi/ UAS-HA-14-3-3ζ
(E and E′), GMR-Gal4 UAS-Yki; UAS-14-3-3εRNAi/UAS-HA-14-3-3ε (F and F′), GMR-Gal4 UAS-Yki;UAS-14-3-3ζRNAi/UAS-HA-14-3-3ε (G and G′), GMR-Gal4 UAS-Yki; UAS-14-3-3ζRNAi/
UAS-HA-14-3-3ζ (H and H′), GMR-Gal4 UAS-Yki (I and I′), GMR-Gal4 UAS-Yki; 14-3-3εj2B10/+ (J and J′), GMR-Gal4 UAS-Yki; 14-3-3ζ12BL/+ (K and K′) and GMR-Gal4 UAS-Yki; 14-3-
3εj2B10/+ 14-3-3ζ12BL/+ (L and L′). Reduction of 14-3-3 either by RNAi knockdown or loss-of-function mutations enhanced the overgrown phenotype caused by Yki overexpression.
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We next investigated whether increasing the level of 14-3-3 could
suppress the phenotype induced by GMR-Yki. UAS-Yki was coex-Fig. 2. Overexpression of either 14-3-3 isoform can suppress Yki-induced eye overgrowth.
GMR-Gal4 UAS-Yki (B and B′), GMR-Gal4 UAS-Yki; UAS-HA-14-3-3ε (C and C′), GMR-Gal4 UA
3-3ζ (E and E′) and GMR-Gal4; UAS-HA-14-3-3ε+ UAS-HA-14-3-3ζ (F and F′).pressed with two copies of either UAS-14-3-3ɛ, UAS-14-3-3ζ or both.
We observed dose-dependent suppression of the GMR-Yki phenotype
by 14-3-3 overexpression (Figs. 2B–E′). Overexpression of UAS-14-3-
3ɛ and UAS-14-3-3ζ with GMR-Gal4 did not signiﬁcantly affect eye(A–F′) Side views (A–F) or dorsal views (A′–F′) of adult eyes of GMR-Gal4 (A and A′),
S-Yki; UAS-HA-14-3-3ζ (D and D′), GMR-Gal4 UAS-Yki; UAS-HA-14-3-3ε+ UAS-HA-14-
Fig. 4. Multiple phosphorylation events contribute to Yki regulation. (A–D′) Side views (A–
YkiS168A (B and B′), UAS-Myc-YkiS111,250A (C and C′) or UAS-Myc-Yki3SA (D and D′) with GMR-G
an Sd-luciferase reporter gene, with or without Hpo and Wts expressing constructs. Cell l
(triplicate wells). Numbers indicate degrees of suppression of Yki/Sd activity by Hpo/Wts.
Fig. 3. Loss of 14-3-3 results in nuclear accumulation of Yki. (A and B) Low (A) and high
(B) magniﬁcation view of a wild-type wing disc immunostained with an anti-Yki
(green) antibody. Yki is primarily localized in the cytoplasm. (C–D″) Low (C) and high
(D–D″) magniﬁcation view of a wing disc expressing both UAS-14-3-3ɛ RNAi and UAS-
14-3-3ζ RNAi together with UAS-P35 using MS1096 and immunostained with anti-Yki
antibody (green in C, D and D″) and 7-AAD (red in D′ and D″) to label the nuclei. The
wing disc is oriented with anterior to the left and ventral up. Severe knockdown of both
14-3-3 isoforms in the dorsal region of the wing pouch resulted in nuclear
accumulation of endogenous Yki.
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of-function studies suggested that both 14-3-3 isoforms participate in
restricting Yki activity.
Loss of 14-3-3 results in nuclear accumulation of Yki
To determine whether 14-3-3 regulates Yki activity by inhibiting
its nuclear localization, we examined the subcellular localization of
endogenous Yki in either wild-type wing discs or wing discs
expressing both 14-3-3ɛ and 14-3-3ζ RNAi transgenes under the
control of the wing-speciﬁc Gal4 driverMS1096. As 14-3-3 function is
required for many cellular processes, a more complete loss of 14-3-3
could result in cell lethality. We therefore coexpressed a cell death
inhibitor P35 (Hay et al., 1994) together with 14-3-3 RNAi transgenes
to increase the survival of cells lacking 14-3-3 activity. Consistent with
previous observations (Dong et al., 2007; Oh and Irvine, 2008), the
endogenous Yki was predominantly localized in the cytoplasm
(Figs. 3A and B). In 14-3-3 knockdown wing discs, Yki was accumu-
lated in the nucleus (Figs. 3C–D″), particularly in the dorsal com-
partment cells where MS1096-gal4 expression is higher (Wang et al.,
1999). These results demonstrated that 14-3-3 is required for the
nuclear exclusion of Yki.
Yki activity is regulated by multiple phosphorylation events
It has been shown that Yap is regulated by phosphorylation at
multiple sites that fall into the consensus sequence: HXRXXS (Hao et
al., 2008; Zhao et al., 2007). Besides Yki Ser168, which is equivalent to
Yap Ser127, two additional sites (Ser111 and Ser250) fall into the
same consensus (Fig. 6A). To determine whether phosphorylation at
Ser111 and Ser250 modulates Yki activity, we mutated them into Ala
in otherwise wild-type background (YkiS111,250A) or in the back-
ground where Ser168 was also mutated into Ala (Yki3SA). To directly
compare their activities with those of wild-type Yki and YkiS168A
without evoking the difference in the levels of transgene expression,
transformants for Myc-taggedwild-type Yki (Myc-Yki) or Yki variants
(Myc-YkiS168A, Myc-YkiS111,250A and Myc-Yki3SA) were generatedD) or dorsal views (A′–D′) of adult eyes expressing UAS-Myc-Yki (A and A′), UAS-Myc-
al4. (E) S2 cells were transfected with the indicated Yki constructs together with Sd and
ysates were subjected to dual luciferase assay. Error bars indicate standard deviation
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were expressed at the same level (Bischof et al., 2007). Consistent
with our previous observation (Zhang et al., 2008), Myc-Yki induced
only modest overgrowth when expressed posterior to the MF using
the GMR-Gal4 driver (Figs. 4A, A′). In contrast, GMR-Myc-YkiS168A
induced more dramatic eye overgrowth (Figs. 4B, B′). Interestingly,Fig. 5. Phosphorylation at S111 and S250 restricts Yki nuclear localization. (A–D′) S2 cells
YkiS111,250A (C and C′) or Myc-Yki3SA (D and D′) with (A′–D′) or without Fg-Hpo (A–D) w
magniﬁcation views of wing discs expressing HA-Sd and Myc- YkiWT (E), Myc-YkiS168A (F), M
(green) and anti-HA (red) antibodies.GMR-Myc-YkiS111,250A also induced enlarged eyes although the
phenotype was weaker than that of GMR-Myc-YkiS168A but stronger
than GMR-Myc-Yki (Figs. 4C, C′). Finally, Myc-Yki3SA appeared to be
more potent than Myc-YkiS168A as it induced more profound
overgrowth than Myc-YkiS168A when expressed using GMR-Gal4
(Figs. 4D, D′). As all the transgenes were inserted into the sameexpressing HA-Sd together with Myc-YkiWT (A and A′), Myc-YkiS168A (B and B′), Myc-
ere immunostained with anti-Myc (green) and anti-HA (red) antibodies. (E–H) High-
yc-YkiS111,250A (G) or Myc-Yki3SA (H) usingMS1096 and immunostained with anti-Myc
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the difference in the overgrowth phenotypes induced by different
forms of Yki reﬂected the difference in their activities.
To further conﬁrm that Yki activity is regulated by multiple
phosphorylation events, we directly measured the activity of Yki
variants using the sd-luciferase reporter assay (Zhang et al., 2008). As
shown in Fig. 4E, Yki variants exhibited higher activity than the
wild-type Yki with the order of Yki3SANYkiS168ANYkiS111,250ANYkiWT,
which is consistent with the in vivo activity exhibited by these Yki
variants. In addition, Yki variants were more resistant to Hpo-
mediated inhibition. Taken together, these results demonstrated
that, besides phosphorylation at S168, phosphorylation at S111 and
S250 also inhibited Yki activity, albeit to a lesser extent than S168
phosphorylation.
Regulation of Yki subcellular localization by phosphorylation at S111
and S250
It has been shown that Hpo signaling inhibits Yki nuclear
localization by phosphorylating Yki at S168 (Dong et al., 2007; Oh
and Irvine, 2008; Zhang et al., 2008). To investigate whether phos-
phorylation at S111 and S250 also modulated Yki nuclear localization,
we examined the subcellular localization of YkiS111,250A in S2 cells and
wing disc cells. We have shown previously that Sd facilitates Yki
nuclear localization in both S2 cells and wing imaginal discs (Zhang
et al., 2008). In agreement with these previous ﬁndings, Myc-YkiWT
exhibited signiﬁcant nuclear signal when coexpressed with HA-Sd but
was excluded from the nucleus in the presence of Flag-Hpo
coexpression (Figs. 5A, A′). In contrast, Myc-YkiS168A exhibited more
profound nuclear localization thanMyc-YkiWT when coexpressed with
HA-Sd and a signiﬁcant portion of Myc-YkiS168A remained in the
nucleus when Flag-Hpo was coexpressed (Figs. 5B, B′). Myc-
YkiS111,250A also exhibited higher levels of nuclear signal than Myc-
YkiWT and nuclear YkiS111,250A signalwas readily detectable when Flag-
Hpo was coexpressed (Figs. 5C, C′). However, the levels of nuclear
Myc-YkiS111,250A appeared to be lower than those of Myc-YkiS168A (cf.
Fig. 5C with Fig. 5B, also see Fig. 6C and Fig. 7 for quantiﬁcation).
Finally, Myc-Yki3SA was predominantly localized in the nucleus when
coexpressed with HA-Sd and the majority of Myc-Yki3SA remained in
the nucleus even when Flag-Hpo was coexpressed (Figs. 5D, D′).
We observed a similar trend of nuclear localization of Yki variants in
wing imaginal discs. When coexpressed with HA-Sd using theMS1096
Gal4 driver, Myc-YkiS111,250A exhibited increased nuclear localization as
compare with Myc-YkiWT (cf. Fig. 5G with Fig. 5E) whereas both Myc-
YkiS168A and Myc-Yki3SA were predominantly nuclear (Figs. 5F, H).
Thus, mutating S111 and S250 facilitated Yki nuclear localization, albeit
less dramatically compared with S168A mutation.
Regulation of Yki subcellular localization by 14-3-3 is mediated by
phosphorylation at S168 but is independent of phosphorylation at
S111 and S250
Phosphorylation of YkiS168/YapS127 generates a 14-3-3 binding
site that fall into the consensus RXXSpXP (Dong et al., 2007; Oh and
Irvine, 2008; Zhao et al., 2007). In contrast, phosphorylation at S111 or
S250 does not generate a 14-3-3 binding consensus site because aFig. 6. Phosphorylation at S111 and S250 regulates Yki independent of 14-3-3. (A) The alignm
Wts phosphorylation site indicated underneath. X: any amino acid. (B) Mutating S111 and S
were transfected with indicated Myc-tagged wild-type and mutant Yki constructs and
immunoprecipitation and western blot analyses with indicated antibodies. (C) 14-3-3 regu
HA-SD, Myc-YkiS111,250A or Myc-YkiS168A, without or with coexpression of Hpo or Hpo plu
localization of Myc-YkiS111,250A or Myc-YkiS168A was monitored using confocal microscopy. C
total of 100 cells were counted for each Yki construct. CNN: cells contain higher levels of Y
cytoplasm and nucleus. NNC: cells contain higher levels of Yki in the nucleus than in the cyto
dorsal (bottom) views of adult eyes expressing GMR-Gal4 UAS-Yki (D), GMR-Gal4 UAS-YkiS111
and 14-3-3 (D″–G″) were coexpressed with the wild-type or mutant Yki as indicated.critical Pro residue C-terminal to the phospho-Ser residue is missing
(Fig. 6A), implying that regulation of Yki by these two phosphoryla-
tion sites is 14-3-3 independent. To conﬁrm that phosphorylation at
Ser111 and 250 does not render 14-3-3 binding, we carried out
immunoprecipitation experiments to determine the interaction be-
tween 14-3-3 with various Yki mutants. As shown in Fig. 6, HA-14-3-3
was coimmunoprecipitated with Myc-YkiWT and the interaction
between 14-3-3 and Myc-YkiWT increased dramatically when the
Hpo/Wts/Mats complex was coexpressed (Fig. 6B, lanes 1 and 5).
Mutating S111 and S250 did not affect either the basal or Hpo
signaling-induced 14-3-3 binding (Fig. 6B, lanes 3 and 7). In contrast,
mutating S168 completely abolished both the basal and Hpo signaling-
induced 14-3-3 binding (Fig. 6B, lanes 2 and 6). Myc-Yki3SA and Myc-
YkiS168A behaved similarly with respect to 14-3-3 binding (cf. lanes 4
and 8 with lanes 2 and 6). Consistent with the observations that
phosphorylation at S168 but not at S111 and S250 promotes 14-3-3
binding, Hpo-mediated inhibition of Myc-YkiS111,250A nuclear localiza-
tion was enhanced by coexpression of 14-3-3 in S2 cells (Fig. 6C). In
contrast, Hpo-mediated inhibition of Myc-YkiS168A nuclear localization
was not signiﬁcantly affected by 14-3-3 coexpression. Thus, phosphor-
ylation at S111 and S250 does not regulate Yki/14-3-3 association and
nuclear restriction of Yki by 14-3-3.
In corroboration with the observations obtained in S2 cells, 14-3-3
cooperated with the Hpo kinase domain (HpoN) to inhibit the
overgrowth phenotypes caused by overexpression of Yki or
YkiS111,250A (Figs. 6D–D″ and E–E″). In contrast, 14-3-3 did not colla-
borate with HpoN to suppress the overgrowth phenotypes caused by
overexpression of YkiS168A or Yki3SA (Figs. 6F–F″ and G–G″).
Furthermore, the overgrowth phenotype induced by YkiS111,250A
overexpression was consistently enhanced by 14-3-3 knockdown
(Figs. S1C–D′). In contrast, the overgrowth phenotype caused by
YkiS168A or Yki3SA was not signiﬁcantly enhanced by 14-3-3
knockdown (Figs. S1A–B′ and E–F′). These observations strength the
view that 14-3-3 regulates Yki activity through phosphorylation at
S168whereas phosphorylation at S111 and S250 regulates Yki activity
independent of 14-3-3.
Phosphorylation of Yki does not regulate Ex-mediated inhibition of Yki
It has been shown recently that Ex directly binds Yki and inhibits
its nuclear localization and activity (Badouel et al., 2009). We found
that Ex inhibited the activity of Myc-YkiWT, Myc-YkiS111,250A, Myc-
YkiS168A and Myc-Yki3SA in the sd-luciferase reporter assay (Fig. S2A).
In addition, mutating S111, S168 and S250 did not affect cytoplasmic
sequestration of Yki by Ex (Fig. S2B), suggesting that phosphorylation
of Yki at S111, S168 and S250 as well as 14-3-3 binding is not required
for Ex-mediated inhibition of Yki.
Regulation of Yki subcellular localization by CRM1-mediated nuclear
export
Hpo signaling could prevent Yki nuclear localization by impeding
its nuclear import or by promoting its nuclear export. To investigate
whether Yki is regulated by nuclear export, we treated cells
transfected with Yki and Sd expression constructs with leptomycin
B (LMB), a drug that blocks CRM1-dependent nuclear export (Kudoent of Yki sequences surrounding S111, S168 or S250 with the consensus sequence for
250 does not affect 14-3-3 binding but mutating S168 abolishes 14-3-3 binding. S2 cells
HA-14-3-3 constructs with or without Hpo/Wts/Mats coexpression, followed by
lates nuclear localization of YkiS111,250A but not YkiS168A. S2 cells were transfected with
s 14-3-3. Cells were immunostained with Myc and HA antibodies, and the subcellular
ells with different nucleocytoplasmic distributions of Myc-tagged Yki were counted. A
ki in the cytoplasm than in the nucleus. C=N: cells contain Yki equally distributed in
plasm. The y axis indicates the percentage of cells in each category. (D–G″) Side (top) or
,250A (E), GMR-Gal4 UAS-YkiS168A (F) or GMR-Gal4 UAS-Yki3SA (G). HpoN (D′–G′) or HpoN
Fig. 7. Restriction of Yki nuclear localization by Hpo signaling depends on nuclear export. S2 cells were transfected with Myc-tagged wild-type or mutant forms of Yki together with
HA-Sd and with or without a Flag-Hpo expression construct. Cells were treated without or with LMB at a concentration of 20 nM for 4 h, followed by immunostaining with Myc and
HA antibodies. For each Yki construct, 100 cells were randomly selected and Yki subcellular localization was determined using confocal microscopy. CNN: cells contain higher levels
of Yki in the cytoplasm than in the nucleus. C=N: cells contain Yki equally distributed in cytoplasm and nucleus. NNC: cells contain higher levels of Yki in the nucleus than in the
cytoplasm.
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subcellular localization. In the absence of LMB treatment, the majority
of cells (∼70%, N=100) exhibited higher levels of Myc-YkiWT in the
cytoplasm whereas only a small fraction of cells (∼30%, N= 100)
exhibited equal distribution of Myc-YkiWT in the cytoplasm and
nucleus or higher levels of Myc-YkiWT in the nucleus. Strikingly, after
LMB treatment, the majority of cells (N 80%, N= 100) exhibited equal
distribution of Myc-YkiWT in the cytoplasm and nucleus or higher
levels of nuclear Myc-YkiWT (Fig. 7A). In the presence of Flag-Hpo,
N90% (N=100) of cells exhibited exclusive cytoplasmic Myc-YkiWT in
the absence of LMB, whereas after LMB treatment, about 50% of cells
(N= 100) exhibited higher nuclear signals or equal distribution of
nuclear and cytoplasmic signals of Myc-YkiWT (Fig. 7A). LMB
treatment also promoted nuclear localization of Myc-YkiS111,250A,
Myc-YkiS168A and Myc-Yki3SA and interfered with Hpo-mediated
cytoplasmic retention of these Yki variants (Figs. 7B–D). In contrast,
Ex sequestered both Myc-YkiWT and Myc-Yki3SA in the cytoplasm
efﬁciently in the presence of LMB treatment (Fig. S3). Thus,
phosphorylation-mediated inhibition of Yki nuclear localization
critically depends on nuclear export whereas Ex/Yki interaction
inhibits Yki nuclear localization is independent of Yki nuclear export.
Discussion
The Hpo pathway is an evolutionarily conserved pathway that
regulates cell growth, cell proliferation and apoptosis. The transcrip-tional coactivator Yki/YAP is the critical downstream regulatory
target of the Hpo kinase cascade. It has been suggested that regulation
of the subcellular localization of Yki/Yap is the primarymechanism by
which the Hpo pathway inﬂuences gene expression (Pan, 2007; Zhang
et al., 2009). The observation that Hpo signaling regulates Yki nuclear
localization by phosphorylating S168 and phosphorylation at S168
promotes 14-3-3 binding led to the proposal that Hpo signaling-
mediated phosphorylation of Yki at S168 sequesters Yki in the
cytoplasm through 14-3-3 binding. Here we provide genetic evidence
that 14-3-3 inhibits Yki nuclear localization and restricts Yki activity.
As complete loss of 14-3-3 leads to cell lethality due to the
essential roles of 14-3-3 in many cellular processes, we applied RNAi
to partially inactivate 14-3-3 and asked whether Yki activity was
potentiated. Indeed, we found that knockdown of either 14-3-3ɛ or
14-3-3ζ enhanced the overgrowth phenotype induced by GMR-Yki
(Figs. 1C–D′). In addition, removal of one copy of either 14-3-3ɛ or 14-
3-3ζ slightly enhanced the GMR-Yki phenotype whereas removal of
one copy of both 14-3-3ɛ and 14-3-3ζ resulted in a more dramatic
enhancement of the GMR-Yki phenotype (Figs. 1J–L′). On the other
hand, overexpressing either 14-3-3ɛ or 14-3-3ζ can suppress the
GMR-Yki phenotype (Fig. 2). Thus, both loss-of-function and gain-of-
function studies suggest that both 14-3-3 isoforms participate in
restricting Yki activity. Furthermore, we found that knockdown of 14-
3-3 led to nuclear accumulation of endogenous Yki in wing imaginal
disc cells (Fig. 3), suggesting that 14-3-3 inhibits Yki activity by
restricting its nuclear localization.
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phosphorylating Yki at S168, which is equivalent to S127 of Yap.
Phosphorylation at YkiS168/Yap S127 generates 14-3-3 binding site.
Consistent with phosphorylation at this site inhibits Yki nuclear
localization and activity through 14-3-3 binding, we found that the
activity of YkiS168A was not sensitive to changes in 14-3-3 activity as
RNAi knockdown or overexpression of 14-3-3 did not signiﬁcantly
modulate the overgrowth phenotype caused by GMR-YkiS168A (Figs.
6F–F″; Figs. S1A–B′). Moreover, the subcellular localization of YkiS168A
was not inﬂuenced by overexpression of 14-3-3 (Fig. 6C). Taken
together with the biochemical data, these observations suggest
that 14-3-3 regulates Yki nuclear localization and activity through
interaction with phosphorylated Yki at S168.
Although phosphorylation at YkiS168 is a major regulatory
mechanism of Yki nuclear localization and activity, it is not the only
mechanism. Two previous studies revealed that Yap was phosphor-
ylated at 4 additional sites that conform the consensus sequence,
HXRXXS, and that phosphorylation at these sites also inhibited Yap
activity (Hao et al., 2008; Zhao et al., 2007).We found that Yki has two
additional sites that match the same consensus, HSRANS111AD and
HKKQRS250YN (Fig. 6A). Interestingly, mutating Ser 111 and S250 to A
(YkiS111,250A) increased Yki activity (cf. Fig. 4C with Fig. 4A) and
rendered Yki less sensitive to Hpo/Wts-mediated inhibition (Fig. 4E).
Compared with wild-type Yki, YkiS111,250A exhibited increased levels
of nuclear localization in both S2 cells and wing discs (Figs. 5C and G;
cf. Fig. 5A with Fig. 5E). YkiS111,250A appears to be less potent in
inducing overgrowth as compared YkiS168A (Fig. 4). Consistently,
nuclear localization of YkiS111,250A was less profound than that of
YkiS168A (Fig. 5). Finally, Ser 111 and S250 to A mutation had an
additive effect with S168 mutation as Yki3SA exhibited the highest
levels of activity andmore profound nuclear localization than YkiS168A
or YkiS111,250A, suggesting that these phosphorylation events act in
parallel to inhibit Yki nuclear localization and activity. In agreement
with our ﬁndings, Oh and Irvine (2009) also observed that mutating
Yki S111 and S250 enhanced Yki subcellular localization and activity
and rendered Yki less sensitive to Hpo/Wts-mediated inhibition.
Mutating Yki S111 and S250 (YkiS111,250A) did not affect 14-3-3
binding to Yki and phosphorylation at these two sites in the absence
of S168 (YkiS168A) failed to confer any detectable Yki/14-3-3
association (Fig. 6B; Oh and Irvine, 2009). Furthermore, when S127
of Yap was mutated, phosphorylation at other 4 sites failed to recruit
14-3-3 (Hao et al., 2008; Zhao et al., 2007). Consistent with these
biochemical data, we found that YkiS168A, which has intact S111 and
S250, was insensitive to either gain or loss of 14-3-3 activity. On the
other hand, Yki lacking Ser 111 and S250 (YkiS111,250A) was still
inhibited by 14-3-3. These observations support the view that
phosphorylation at Ser 111 and S250 may regulate Yki nuclear
localization and activity independent of 14-3-3 association. A recent
study has revealed that Ex can physically associate with Yki and this
interaction appears to sequester Yki in the cytoplasm. We found that
Ex not only sequestered the wild-type Yki but also the phosphory-
lation deﬁcient forms of Yki (Fig. S2), suggesting that regulation of Yki
nuclear localization by phosphorylation at Ser 111 and S250 is
unlikely mediated by Ex.
How phosphorylation and 14-3-3 binding regulate Yki nuclear
localization is not clear but it appears that nuclear export is required
for restricting Yki nuclear localization in response to Hpo signaling
(Fig. 7). Bind of 14-3-3 to target proteins has been suggested to
regulate nucleocytoplasmic shuttling by impeding nuclear import
and/or promoting nuclear export (Brunet et al., 2002; Kumagai and
Dunphy, 1999). Yki does not have an intrinsic nuclear localization
signal (NLS) and its nuclear import appears to depend on its binding
partner Sd (Goulev et al., 2008; Zhang et al., 2008). It is not impossible
that binding of 14-3-3 to Yki could mask the NLS of Sd. An alternative
but not mutually exclusive model is that phosphorylation and 14-3-3
binding may facilitate CRM1-mediated nuclear export. Consistentwith this model, we found that blocking CRM1-mediated nuclear
export by LMB treatment effectively prevented cytoplasmic localiza-
tion in response to Hpo signaling. However, since the nuclear levels of
YkiS168A and Yki3SA increased after LMB treatment, Yki can be
exported out of the nucleus even in the absence of Yki phosphory-
lation and 14-3-3 binding. Thus, phosphorylation and 14-3-3 binding
is not absolutely required for but may facilitate Yki nuclear export. In
contrast, Ex-mediated cytoplasmic localization of Yki was not
effectively blocked by LMB treatment (Fig. S3), suggesting that Ex/
Yki interaction may sequester Yki in the cytoplasm independent of
nuclear export. Since Ex can effectively retain YkiS168A and Yki3SA in
the cytoplasm and both YkiS168A and Yki3SA no longer bind 14-3-3, the
regulation of Yki by Ex is likely to be 14-3-3 independent.
CRM1 mediates nuclear export of target proteins through nuclear
export signal (NES) (Fornerod et al., 1997; Fukuda et al., 1997).
Inspection of Yki and Yap sequences identiﬁed multiple NES like
sequences (our unpublished observation). It will be interesting to
determine the roles of these putative NES sequences in regulating
Yki/Yap subcellular localization and activity and how 14-3-3 proteins
control the nucleocytoplasmic shuttling of Yki/Yap. We also note that
the subcellular localization and activity of Yki3SA is still regulated by
Hpo signaling, albeit much less effectively as compared with the wild-
type Yki. Similar observation has been made for the phosphorylation
deﬁcient form of Yap that lacks all the Wts phosphorylation sites
(Zhao et al., 2007). Thus, Hpo signaling may regulate Yki through
additional mechanism(s) independent of its phosphorylation.
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